Investigation of Gal-3 Expression Pattern in Serum and Cerebrospinal Fluid of Patients Suffering From Neurodegenerative Disorders

Investigation of Gal-3 Expression Pattern in Serum and Cerebrospinal Fluid of Patients Suffering From Neurodegenerative Disorders

We performed this study to investigate the possibility of a definitive pattern of Galectin-3 (Gal-3) expression in the cerebrospinal fluid (CSF) and serum of Alzheimer’s disease (AD) and Amyotrophic Lateral Sclerosis (ALS) patients. In our study, we collected the CSF and serum samples of 31 AD patie...

Full description

Bibliographic Details
Main Authors: Ghulam M. Ashraf, Saleh S. Baeesa
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Neuroscience
Subjects:
Galectin-3
serum
cerebrospinal fluid
Alzheimer’s disease
amyotrophic lateral sclerosis
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2018.00430/full

Similar Items

Similar Items